| Product NDC: | 0024-5833 |
| Proprietary Name: | Auvi-Q |
| Non Proprietary Name: | epinephrine |
| Active Ingredient(s): | .3 mg/1 & nbsp; epinephrine |
| Administration Route(s): | INTRAMUSCULAR; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0024-5833 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA201739 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20121115 |
| Package NDC: | 0024-5833-00 |
| Package Description: | 1 INJECTION in 1 CARTON (0024-5833-00) |
| NDC Code | 0024-5833-00 |
| Proprietary Name | Auvi-Q |
| Package Description | 1 INJECTION in 1 CARTON (0024-5833-00) |
| Product NDC | 0024-5833 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | epinephrine |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; SUBCUTANEOUS |
| Start Marketing Date | 20121115 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | EPINEPHRINE |
| Strength Number | .3 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |